Bladder cancer check-up intervals after tumor removal
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares different schedules for follow-up cystoscopies (bladder checks) after surgery for high-grade bladder cancer that hasn't invaded muscle. It aims to find the safest and most effective timing to catch any return of cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran receiving care at a VA medical center (or have approval for VA care).
- You have had high-grade bladder cancer that is not muscle-invasive, confirmed by a recent biopsy or surgery.
- Your bladder cancer treatment followed VA guidelines, such as a second surgery for T1 tumors or intravesical therapy (medicine put directly into the bladder) if needed.
- Your first follow-up cystoscopy (about 3 months after surgery) showed no signs of cancer recurrence, with negative or atypical urine cytology (cell test).
- You can consent in English or Spanish and are willing to follow study procedures.
- You do not have a history of muscle-invasive bladder cancer, cancer in the upper urinary tract (except if removed and no recurrence), or certain rare bladder cancer types.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests non-invasive tests (using urine samples and scheduled bladder procedures) to help detect bladder cancer. It may be helpful if you are having bladder evaluation or surgery and your care team wants better ways to detect cancer without invasive testing beyond what you already need.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study compares two standard treatments for high-grade non-muscle-invasive bladder cancer that has come back after initial treatment: medication placed directly into the bladder (intravesical therapy) or bladder removal surgery (cystectomy). The goal is to see which option works better for patients like you.
This study compares two approaches for people with intermediate-risk bladder cancer whose urine shows no signs of cancer after surgery. One group will be watched closely (active surveillance), while the other will receive chemotherapy directly into the bladder (intravesical chemotherapy). The goal is to see if surveillance alone can prevent unnecessary treatment while keeping the cancer controlled.
This study is collecting blood, urine, and tissue samples from people with high-risk non-muscle invasive bladder cancer to help develop better tests for tracking the disease. By participating, you might help improve future monitoring and treatment decisions.
Hear when a new High-Grade Early-Stage Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.